+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Immunoassay Analyzers Market Research Report by Product, Application, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 159 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5722271
The United States Immunoassay Analyzers Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Immunoassay Analyzers Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Immunoassay Analyzers Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Immunoassay Analyzers Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Immunoassay Analyzers Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Immunoassay Analyzers Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Immunoassay Analyzers Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay.
  • Based on Application, the market is studied across Autoimmune Disease, Cardiology, Endocrinology, Infectious Disease Testing, Oncology, and Therapeutic Drug Monitoring.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Immunoassay Analyzers Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Immunoassay Analyzers Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Immunoassay Analyzers Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Immunoassay Analyzers Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Immunoassay Analyzers Market, including Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, Boditech Med Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and WAK-Chemie Medical GmbH.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Immunoassay Analyzers Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Immunoassay Analyzers Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Immunoassay Analyzers Market?
4. What is the competitive strategic window for opportunities in the United States Immunoassay Analyzers Market?
5. What are the technology trends and regulatory frameworks in the United States Immunoassay Analyzers Market?
6. What is the market share of the leading vendors in the United States Immunoassay Analyzers Market?
7. What modes and strategic moves are considered suitable for entering the United States Immunoassay Analyzers Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High demand for use of immunoassays in oncology and point-of-care testing and rapid testing
5.1.1.2. Stringent U.S. regulations mandating drug and alcohol testing
5.1.2. Restraints
5.1.2.1. Stringent regulation for approvals
5.1.3. Opportunities
5.1.3.1. Integration of advanced technologies and product improvements in immunoassay analyzers
5.1.4. Challenges
5.1.4.1. False readings in immunoassay analyzers
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Immunoassay Analyzers Market, by Product
6.1. Introduction
6.2. Chemiluminescence Immunoassay
6.3. Consumables & Accessories
6.4. Enzyme-linked Immunoassay
6.5. Immunofluorescence Analyzers
6.6. Radioimmunoassay

7. Immunoassay Analyzers Market, by Application
7.1. Introduction
7.2. Autoimmune Disease
7.3. Cardiology
7.4. Endocrinology
7.5. Infectious Disease Testing
7.6. Oncology
7.7. Therapeutic Drug Monitoring

8. California Immunoassay Analyzers Market
8.1. Introduction

9. Florida Immunoassay Analyzers Market
9.1. Introduction

10. Illinois Immunoassay Analyzers Market
10.1. Introduction

11. New York Immunoassay Analyzers Market
11.1. Introduction

12. Ohio Immunoassay Analyzers Market
12.1. Introduction

13. Pennsylvania Immunoassay Analyzers Market
13.1. Introduction

14. Texas Immunoassay Analyzers Market
14.1. Introduction

15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Product Portfolio Analysis, By Key Player
15.5. Competitive Scenario
15.5.1. Merger & Acquisition
15.5.2. Agreement, Collaboration, & Partnership
15.5.3. New Product Launch & Enhancement
15.5.4. Investment & Funding
15.5.5. Award, Recognition, & Expansion

16. Company Usability Profiles
16.1. Abbott Laboratories
16.2. Beckman Coulter, Inc.
16.3. Becton Dickinson and Company
16.4. Bio-Rad Laboratories, Inc.
16.5. bioMérieux SA
16.6. Boditech Med Inc.
16.7. DiaSorin S.p.A.
16.8. F. Hoffmann-La Roche Ltd.
16.9. Merck KGaA
16.10. Ortho-Clinical Diagnostics, Inc.
16.11. Quidel Corporation
16.12. Siemens Healthineers AG
16.13. Sysmex Corporation
16.14. Thermo Fisher Scientific Inc.
16.15. WAK-Chemie Medical GmbH

17. Appendix
17.1. Discussion Guide
17.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES IMMUNOASSAY ANALYZERS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES IMMUNOASSAY ANALYZERS MARKET DYNAMICS
FIGURE 8. UNITED STATES IMMUNOASSAY ANALYZERS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES IMMUNOASSAY ANALYZERS MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES IMMUNOASSAY ANALYZERS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 20. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
FIGURE 26. CALIFORNIA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 27. FLORIDA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 28. ILLINOIS IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. NEW YORK IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. OHIO IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. PENNSYLVANIA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. TEXAS IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 34. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 35. UNITED STATES IMMUNOASSAY ANALYZERS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. CALIFORNIA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 30. CALIFORNIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. CALIFORNIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. FLORIDA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 33. FLORIDA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. FLORIDA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. ILLINOIS IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 36. ILLINOIS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 37. ILLINOIS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. NEW YORK IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. NEW YORK IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. NEW YORK IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. OHIO IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 42. OHIO IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 43. OHIO IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. PENNSYLVANIA IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 45. PENNSYLVANIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. PENNSYLVANIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TEXAS IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 48. TEXAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. TEXAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 51. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 52. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 53. UNITED STATES IMMUNOASSAY ANALYZERS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 54. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 55. UNITED STATES IMMUNOASSAY ANALYZERS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 56. UNITED STATES IMMUNOASSAY ANALYZERS MARKET MERGER & ACQUISITION
TABLE 57. UNITED STATES IMMUNOASSAY ANALYZERS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 58. UNITED STATES IMMUNOASSAY ANALYZERS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 59. UNITED STATES IMMUNOASSAY ANALYZERS MARKET INVESTMENT & FUNDING
TABLE 60. UNITED STATES IMMUNOASSAY ANALYZERS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 61. UNITED STATES IMMUNOASSAY ANALYZERS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • Boditech Med Inc.
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Ortho-Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • WAK-Chemie Medical GmbH

Methodology

Loading
LOADING...